336 related articles for article (PubMed ID: 20722968)
1. The role of endogenous serotonin in methamphetamine-induced neurotoxicity to dopamine nerve endings of the striatum.
Thomas DM; Angoa Pérez M; Francescutti-Verbeem DM; Shah MM; Kuhn DM
J Neurochem; 2010 Nov; 115(3):595-605. PubMed ID: 20722968
[TBL] [Abstract][Full Text] [Related]
2. 3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter.
Anneken JH; Angoa-Pérez M; Kuhn DM
J Neurochem; 2015 Apr; 133(2):211-22. PubMed ID: 25626880
[TBL] [Abstract][Full Text] [Related]
3. Effects of combined treatment with mephedrone and methamphetamine or 3,4-methylenedioxymethamphetamine on serotonin nerve endings of the hippocampus.
Angoa-Pérez M; Kane MJ; Herrera-Mundo N; Francescutti DM; Kuhn DM
Life Sci; 2014 Feb; 97(1):31-6. PubMed ID: 23892197
[TBL] [Abstract][Full Text] [Related]
4. Increases in cytoplasmic dopamine compromise the normal resistance of the nucleus accumbens to methamphetamine neurotoxicity.
Thomas DM; Francescutti-Verbeem DM; Kuhn DM
J Neurochem; 2009 Jun; 109(6):1745-55. PubMed ID: 19457119
[TBL] [Abstract][Full Text] [Related]
5. Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMA.
Angoa-Pérez M; Kane MJ; Briggs DI; Francescutti DM; Sykes CE; Shah MM; Thomas DM; Kuhn DM
J Neurochem; 2013 Apr; 125(1):102-10. PubMed ID: 23205838
[TBL] [Abstract][Full Text] [Related]
6. Methamphetamine oxidative stress, neurotoxicity, and functional deficits are modulated by nuclear factor-E2-related factor 2.
Ramkissoon A; Wells PG
Free Radic Biol Med; 2015 Dec; 89():358-68. PubMed ID: 26427884
[TBL] [Abstract][Full Text] [Related]
7. Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation.
Thomas DM; Walker PD; Benjamins JA; Geddes TJ; Kuhn DM
J Pharmacol Exp Ther; 2004 Oct; 311(1):1-7. PubMed ID: 15163680
[TBL] [Abstract][Full Text] [Related]
8. Methamphetamine-induced neurotoxicity and microglial activation are not mediated by fractalkine receptor signaling.
Thomas DM; Francescutti-Verbeem DM; Kuhn DM
J Neurochem; 2008 Jul; 106(2):696-705. PubMed ID: 18410508
[TBL] [Abstract][Full Text] [Related]
9. The newly synthesized pool of dopamine determines the severity of methamphetamine-induced neurotoxicity.
Thomas DM; Francescutti-Verbeem DM; Kuhn DM
J Neurochem; 2008 May; 105(3):605-16. PubMed ID: 18088364
[TBL] [Abstract][Full Text] [Related]
10. The effects of methamphetamine on serotonin transporter activity: role of dopamine and hyperthermia.
Haughey HM; Fleckenstein AE; Metzger RR; Hanson GR
J Neurochem; 2000 Oct; 75(4):1608-17. PubMed ID: 10987842
[TBL] [Abstract][Full Text] [Related]
11. Inhibitors of Na(+)/H(+) and Na(+)/Ca(2+) exchange potentiate methamphetamine-induced dopamine neurotoxicity: possible role of ionic dysregulation in methamphetamine neurotoxicity.
Callahan BT; Cord BJ; Yuan J; McCann UD; Ricaurte GA
J Neurochem; 2001 Jun; 77(5):1348-62. PubMed ID: 11389186
[TBL] [Abstract][Full Text] [Related]
12. Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter.
Fumagalli F; Gainetdinov RR; Valenzano KJ; Caron MG
J Neurosci; 1998 Jul; 18(13):4861-9. PubMed ID: 9634552
[TBL] [Abstract][Full Text] [Related]
13. Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment.
Gluck MR; Moy LY; Jayatilleke E; Hogan KA; Manzino L; Sonsalla PK
J Neurochem; 2001 Oct; 79(1):152-60. PubMed ID: 11595767
[TBL] [Abstract][Full Text] [Related]
14. Genetic or pharmacological blockade of noradrenaline synthesis enhances the neurochemical, behavioral, and neurotoxic effects of methamphetamine.
Weinshenker D; Ferrucci M; Busceti CL; Biagioni F; Lazzeri G; Liles LC; Lenzi P; Pasquali L; Murri L; Paparelli A; Fornai F
J Neurochem; 2008 Apr; 105(2):471-83. PubMed ID: 18042179
[TBL] [Abstract][Full Text] [Related]
15. Role of tumor necrosis factor-alpha in methamphetamine-induced drug dependence and neurotoxicity.
Nakajima A; Yamada K; Nagai T; Uchiyama T; Miyamoto Y; Mamiya T; He J; Nitta A; Mizuno M; Tran MH; Seto A; Yoshimura M; Kitaichi K; Hasegawa T; Saito K; Yamada Y; Seishima M; Sekikawa K; Kim HC; Nabeshima T
J Neurosci; 2004 Mar; 24(9):2212-25. PubMed ID: 14999072
[TBL] [Abstract][Full Text] [Related]
16. Dopamine disposition in the presynaptic process regulates the severity of methamphetamine-induced neurotoxicity.
Kuhn DM; Francescutti-Verbeem DM; Thomas DM
Ann N Y Acad Sci; 2008 Oct; 1139():118-26. PubMed ID: 18991856
[TBL] [Abstract][Full Text] [Related]
17. Evidence against an essential role of endogenous brain dopamine in methamphetamine-induced dopaminergic neurotoxicity.
Yuan J; Callahan BT; McCann UD; Ricaurte GA
J Neurochem; 2001 Jun; 77(5):1338-47. PubMed ID: 11389185
[TBL] [Abstract][Full Text] [Related]
18. Dissociation between hypothermia and neurotoxicity caused by mephedrone and methcathinone in TPH2 knockout mice.
Anneken JH; Angoa-Perez M; Sati GC; Crich D; Kuhn DM
Psychopharmacology (Berl); 2019 Mar; 236(3):1097-1106. PubMed ID: 30074064
[TBL] [Abstract][Full Text] [Related]
19. Disparity in the temporal appearance of methamphetamine-induced apoptosis and depletion of dopamine terminal markers in the striatum of mice.
Zhu JP; Xu W; Angulo JA
Brain Res; 2005 Jul; 1049(2):171-81. PubMed ID: 16043139
[TBL] [Abstract][Full Text] [Related]
20. Methyllycaconitine prevents methamphetamine-induced effects in mouse striatum: involvement of alpha7 nicotinic receptors.
Escubedo E; Chipana C; Pérez-Sánchez M; Camarasa J; Pubill D
J Pharmacol Exp Ther; 2005 Nov; 315(2):658-67. PubMed ID: 16076935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
